Rat angiotensin-converting enzyme promoter regulation by beta-adrenergics and cAMP in endothelium

Citation
J. Xavier-neto et al., Rat angiotensin-converting enzyme promoter regulation by beta-adrenergics and cAMP in endothelium, HYPERTENSIO, 34(1), 1999, pp. 31-38
Citations number
45
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
HYPERTENSION
ISSN journal
0194911X → ACNP
Volume
34
Issue
1
Year of publication
1999
Pages
31 - 38
Database
ISI
SICI code
0194-911X(199907)34:1<31:RAEPRB>2.0.ZU;2-0
Abstract
To shed light on mechanisms of angiotensin-converting enzyme (ACE) upregula tion, we used a rabbit endothelial cell model to characterize intracellular pathways of beta-adrenergic stimulation. In these cells, ACE activity is i ncreased by isoproterenol (ISO). The stably transfected 1273-bp ACE promote r is stimulated by ISO in the presence of isobutyl methylxanthine. This eff ect is abolished by propranolol. Promoter stimulation is mimicked by choler a toxin, forskolin, and 8BrcAMP, but not by 8BrcGMP. Promoter stimulation b y ISO and isobutyl methylxanthine is blocked by protein kinase A inhibitors , indicating that beta-adrenergic stimulation of the ACE gene depends on ph osphorylation of protein kinase A targets. Activation by cAMP, resistance t o phorbol ester, and lack of synergism between cAMP and phorbol ester sugge st that promoter regulation is due to cAMP responsive element rather than t o activating protein-2 sequences. Okadaic acid potentiation of 8BrcAMP indu ction indicated that promoter activation by cAMP is regulated by phosphatas es controlling activation of typical cAMP responsive element regulated gene s. In summary, beta-adrenergic activation of rat ACE promoter is specific; uses G(s) proteins, adenylyl cyclase, protein kinase A; and probably includ es cAMP responsive element-like sequences.